Study of the early prediction and evaluation of the effect of Jianpi Bushen Decoction on Avascular Necrosis of the Femoral Head at ARCO stages 2 and 3 based on CT radiomics and deep learning

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2022000052

Enrollment

Unknown

Registered

2022-06-19

Start date

2022-08-10

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis of the Femoral Head

Interventions

prospective case group:Jianpi Bushen Decoction

retrospective case group:Jianpi Bushen Decoction

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with avascular necrosis of the femoral head treated with Jianpi Bushen Decoction with the syndrome of phlegm and blood stasis blocking collaterals, and the age is greater than or equal to 18 years old. All patients signed informed consent and voluntarily participated in this trial.

Exclusion criteria

Exclusion criteria: ?Age less than 18 years old; ?Rheumatic immune diseases, such as connective tissue disease, ankylosing spondylitis, etc.; ?Severe hip osteoarthritis on the image; ?History of hip trauma; ?History of hip surgery or invasive examination and treatment; ?Incomplete clinical data, no Harris score of hip joint; ?Treatment time is less than 6 months; ?There is nofollow-up image data, or the image data is incomplete and the image quality is poor.

Design outcomes

Primary

Measure	Time frame
femoral head collapse depth;CT Radiomics Features-Gray Statistical Features;CT radiomic features - shape features;CT radiomic features-texture features;	—

Countries

China

Contacts

Public ContactXuedong Yang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

yangxuedong1@163.com01088001420

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026